Global Intrauterine Coil Market Size By Type (Hormonal type, Copper type), By Application (Age 20-24, Age 25-34), By Region, And Segment Forecasts, 2023 to 2032

The Global Intrauterine Coil Market was valued at USD 1.4 billion in 2023 and is projected to reach USD 2.8 billion by 2031, growing at a CAGR of 9.2% during the forecast period from 2023 to 2031. The rising preference for long-acting reversible contraceptives (LARCs), increasing awareness about reproductive health, and advancements in intrauterine device (IUD) designs are significantly driving the market growth. Intrauterine coils, commonly known as IUDs, are considered highly effective birth control options, widely accepted for their long-term reliability and minimal maintenance.

Drivers:

1. Increasing Demand for Long-Acting Reversible Contraceptives (LARCs):

Women globally are increasingly shifting toward contraceptive methods that offer long-term effectiveness with minimal user intervention. Intrauterine coils are gaining popularity due to their high efficacy, safety, and cost-effectiveness over time.

2. Rising Awareness and Access to Family Planning Services:

Government and non-government initiatives promoting family planning and reproductive health, especially in developing regions, are boosting the adoption of intrauterine coils. Enhanced accessibility through clinics and public healthcare programs is a crucial growth factor.

3. Technological Advancements in IUD Design:

Modern IUDs are now designed with hormone-releasing mechanisms, improved biocompatible materials, and user-friendly insertion systems, leading to greater comfort and reduced side effects.

Restraints:

1. Risk of Side Effects and Health Concerns:

Despite their benefits, intrauterine coils may pose risks such as uterine perforation, pelvic inflammatory disease (PID), or irregular bleeding, which may deter some women from opting for this method.

2. Cultural and Religious Opposition:

In certain regions, cultural norms and religious beliefs may limit the acceptance of intrauterine devices, restraining market penetration and growth.

Opportunity:

1. Market Penetration in Emerging Economies:

Emerging countries in Asia-Pacific, Africa, and Latin America present untapped growth opportunities due to large reproductive-age populations and ongoing efforts to improve access to women's health services.

2. Integration with Digital Health Services:

The integration of IUD-based contraceptive care with telehealth and digital platforms can improve patient education, appointment scheduling, and post-insertion monitoring, paving the way for increased adoption.

Market by System Type Insights:

Based on system type, Hormonal Intrauterine Coils dominated the market in 2023, driven by their ability to regulate menstrual cycles, reduce menstrual pain, and offer longer contraceptive effectiveness. However, the Copper Intrauterine Coils segment continues to hold a significant share, especially among women preferring hormone-free birth control methods. Both segments are expected to see healthy growth, with hormonal types leading in terms of innovation and demand.

Market by End-use Insights:

The Hospitals segment held the largest market share in 2023 due to the availability of trained healthcare professionals, sterile environments for IUD insertion, and broader insurance coverage. Gynecology Clinics and Family Planning Centers are also emerging as preferred settings, especially in urban areas, due to convenience, cost-effectiveness, and accessibility.

Market by Regional Insights:

North America led the global intrauterine coil market in 2023, supported by high awareness, favorable insurance reimbursement, and a well-established healthcare system. Europe follows closely with a high adoption rate across Western countries. Asia-Pacific is expected to register the fastest CAGR during the forecast period, with increasing government support for family planning, expanding healthcare access, and growing public awareness in countries like India and China.

Competitive Scenario:

Key players in the global intrauterine coil market include Bayer AG, Teva Pharmaceutical Industries Ltd., CooperSurgical Inc., DKT International, Meril Life Sciences, OCON Healthcare, Pregna International Ltd., and Medicines360. These companies are focused on strategic initiatives such as:

Product innovation, e.g., smaller and lower-dose hormonal IUDs.

Expansion into emerging markets via partnerships with public health agencies.

R&D investment for developing next-generation IUDs with improved safety and extended efficacy.

Scope of Work – Global Intrauterine Coil Market

Report Metric Details

Market Size (2023) USD 1.4 billion

Projected Market Size (2031) USD 2.8 billion

CAGR (2023–2031) 9.2%

Market Segments By System Type (Hormonal, Copper), By End-use (Hospitals, Clinics)

Growth Drivers Rising demand for LARCs, awareness of reproductive health

Opportunities Expansion in emerging markets, digital integration of women’s health

Key Market Developments:

2023: Bayer AG launched a next-gen hormonal IUD with extended duration and lower hormone release for enhanced user comfort.

2024: CooperSurgical expanded its product portfolio by acquiring a startup specializing in copper-based IUDs designed for adolescents and first-time users.

2025: DKT International scaled distribution of affordable IUDs in Sub-Saharan Africa through strategic partnerships with NGOs and government health programs.

FAQs:

1. What is the current market size of the Global Intrauterine Coil Market?

The market was valued at USD 1.4 billion in 2023.

2. What is the major growth driver of the Global Intrauterine Coil Market?

The primary growth driver is the rising adoption of long-acting reversible contraceptives (LARCs).

3. Which is the largest region during the forecast period in the Global Intrauterine Coil Market?

North America holds the largest market share, while Asia-Pacific is expected to grow the fastest.

4. Which segment accounted for the largest market share in Global Intrauterine Coil Market?

The Hormonal Intrauterine Coil segment dominated the market in 2023.

5. Who are the key market players in the Global Intrauterine Coil Market?

Major players include Bayer AG, Teva Pharmaceutical, CooperSurgical, Meril Life Sciences, and DKT International.